menu
    • menu

    Company profile for SonoThera

    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to develop genetic medicines that treat the root cause of human disease. SonoThera is expanding the possibilities of disease treatment with ultrasound-guided nonviral gene therapy for diseases with suboptimal or non-existent treatments. We aim to improve the lives and health of millions of people.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SonoTheraUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    South San Francisco, CA
    Telephone
    Telephone
    14153767840
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sonothera.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sonothera/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sonothera Launches $125M Series B At J.P. Morgan Healthcare Conf
    Sonothera Launches $125M Series B At J.P. Morgan Healthcare Conf

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108648924/en/SonoThera-Launches-%24125M-Series-B-at-44th-J.P.-Morgan-Healthcare-Conference-to-Advance-Multiple-Genetic-Medicine-Programs-Toward-First-in-Human-Studies

    BUSINESSWIRE
    08 Jan 2026
    Share Share
    SonoThera Shows Sustained Factor VIII in Hemophilia A Trial
    SonoThera Shows Sustained Factor VIII in Hemophilia A Trial

    08 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251208394265/en/SonoThera-Presents-New-Data-at-ASH-2025-Demonstrating-Durable-Factor-VIII-Expression-Using-Ultrasound-Mediated-Gene-Delivery-in-Treating-Hemophilia-A

    BUSINESSWIRE
    08 Dec 2025
    Share Share
    Sonothera Shows Ultrasound Gene Delivery Treats Alport Syndrome
    Sonothera Shows Ultrasound Gene Delivery Treats Alport Syndrome

    05 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251105732332/en/SonoThera-Presents-New-Data-at-ASN-Kidney-Week-2025-Demonstrating-Full-Length-Col4a5-Gene-Expression-Using-Ultrasound-Mediated-Gene-Delivery-in-Treating-X-Linked-Alport-Syndrome

    BUSINESSWIRE
    05 Nov 2025
    Share Share
    SonoThera Shows Dystrophin Expression Via Ultrasound In DMD
    SonoThera Shows Dystrophin Expression Via Ultrasound In DMD

    07 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-07/sonothera-presents-new-data-at-esgct-2025-demonstrating-expression-of-full-length-human-dystrophin

    PHARMIWEB
    07 Oct 2025
    Share Share
    SonoThera™ to Present New Data at ASGCT 2025 on Genetic Medicine
    SonoThera™ to Present New Data at ASGCT 2025 on Genetic Medicine

    06 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250506872097/en/SonoThera-to-Present-New-Data-at-ASGCT-2025-Demonstrating-the-Potential-of-Genetic-Medicine-Using-Targeted-Ultrasound-Mediated-Delivery-in-Treating-Duchenne-Muscular-Dystrophy-and-Hemophilia-A

    BUSINESSWIRE
    06 May 2025
    Share Share
    SonoThera Shows Genetic Medicine Potential at 2025 MDA Conference
    SonoThera Shows Genetic Medicine Potential at 2025 MDA Conference

    10 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250310111305/en

    BUSINESSWIRE
    10 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search